Ninvasive Cardiac Output Measurements During Cesarean Delivery Under Spinal Anesthesia.

NCT ID: NCT01928797

Last Updated: 2017-11-14

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2013-11-01
• Study Completion Date: 2014-12-31

Brief Summary

The purpose of the study is to learn more about how the heart works during cesarean delivery under spinal anesthesia (medicines given in the spine that numb parts of your body to block pain) in women. The investigators would like to find out if the information about the heart can help in treating blood pressure changes that occur during the cesarean delivery. The investigators would also like to find out if this information can help reduce the chances of nausea and vomiting during the cesarean delivery.

The activity of the heart changes during spinal anesthesia and cesarean section. In the past, a sensor placed directly into the heart was the only way to see how the heart worked. Currently, there are monitors that can sense the heart's activity via sensors that are placed on the skin during cesarean delivery.

In this study, the investigators will use the ICON cardiac output (ICON) monitor. The ICON monitor is approved by the US Food and Drug Administration (FDA) to monitor (check) the activity of your heart.

This study aims to:

1. Determine if additional cardiac output measurements help anesthesiologists maintain appropriate hemodynamics as defined as within 20% of baseline BP and if it changed their choice of vasopressors (primary outcome).

2. Determine if additional cardiac output measurements help to decrease the incidence of nausea and vomiting during cesarean delivery (secondary outcome).

Detailed Description

Most women who undergo elective cesarean delivery in our hospital have spinal anesthesia for the surgery. You will receive standard spinal anesthesia techniques whether or not you take part in this study. You will be asked to sign a separate clinical consent form for the spinal anesthesia and for your cesarean delivery.

After the anesthesiologist places your spinal anesthesia, the investigator will record your blood pressure every two minutes as is the standard practice in our institution. An anesthesiologist is a doctor who specializes in giving drugs or other agents to prevent or relieve pain during surgery or other procedures. The investigator will also continuously record your heart rate and the amount of oxygen in your blood as is the standard practice. If needed, the anesthesiologist will give you medications to maintain your blood pressure.

In addition to the standard procedures described above, additional monitoring (checking) of your heart will be performed as part of this study. The investigator will use the ICON monitor to measure the amount of blood pumped by each heart beat.

The anesthesiologist will put on the sensors (sticky pads). There are four sticky pads that are similar to what is used during electrocardiograms (EKGs). Two sensors are placed on the left side of your neck and two on the left side of your trunk. The sensors have wires attached that will be plugged into a small heart monitor device that records the information.

The investigators will place the sensors on you before you receive the spinal anesthesia. The sensors will record what your heart is doing before placement of spinal anesthesia until the end of your surgery.

The investigators will assign you by chance (like a coin toss) to one of the following groups:

• Group Study: Your anesthesiologist will have access to the amount of blood that is pumped during each heart beat. The anesthesiologist will treat and maintain the amount of blood pumped during each beat so that it is within the normal range.
• Group Control: Your anesthesiologist will NOT have access to the amount of blood that is pumped during each heart beat. The anesthesiologist will treat and maintain your blood pressure throughout your delivery. (This is the current routine care.)

The control group and the study group will receive spinal anesthesia as is adapted in our institution. HR and BP will be measured every two minutes as is normal practice. Cardiac output will be measured in all patients in both groups. The subjects will have four surface ECG electrodes attached to the left side of the neck and the lower thorax (at the level of the xiphoid). Baseline hemodynamic parameters (SV (stroke volume), HR (heart rate), CO (cardiac output) , SVV (stroke volume variation), and SVR (systemic vascular resistance)) will be determined before placing spinal anesthesia. Continuous CO data will be recorded by the unit.

In the study group, phenylephrine and ephedrine will be used depending on the blood pressure and cardiac output data. If the CO is normal, and BP is below 20% of baseline, phenylephrine boluses of 40 micrograms at two minute interval (BP recording time) will be used to maintain BP within 20% of the baseline. If the BP is normal, but CO is lower than 20% baseline, ephedrine boluses (10 mg) will be used. If BP and CO is lower, a combination of both phenylephrine and ephedrine will be used.

In the control group, the phenylephrine and ephedrine will be used as considered appropriate to maintain BP within 20% of baseline. The CO data will be blinded to the anesthesiologists in the control group

Study group (algorithm in detail):

1. If SBP<20%, CO is within (<,± ) 20% of baseline: Phenylephrine 40 mic boluses to bring BP within 20% of the baseline.

2. If CO < 20%, and BP is within (<,± ) 20% of baseline, ephedrine boluses to bring the CO.

3. If both are below 20% of baseline, phenylephrine 40 mic boluses and ephedrine 10 mg together will be used at 2 min intervals until both reach to within 20% of baseline.

4. If SBP is normal, and CO is greater than 20% baseline, no treatment needed.

5. If CO is normal, and SBP is greater than 20%, no treatment needed.

Control group:

Although BP and CO are being measured in the control group, CO data is blinded to the clinician. Therefore the clinician will use SPB data and current practice instincts to choose either of vasopressors considered appropriate to treat hypotension.

The anesthesiologist has his or her discretion of treating BP, or CO if these parameters are not corrected with above protocol.

Fluid inputs and outputs will be noted that includes blood loss. Apgar scores of newborns will be obtained from neonatologists' assessment. Incidence of nausea and vomiting and medications used will be also noted.

The regional techniques will follow the standards adopted by our institution. Most placements are done in the sitting position. After disinfecting the skin with betadine in the usual fashion, the patients back will be draped with a sterile clear plastic and local anesthetic (1.5 % lidocaine, 2ml) injected at the site of placement. A 3 1/2 -inch 25-gauge Whittaker needle will be inserted into the spinal space at either the L3-L4 or L4-L5. Once the clear Cerebrospinal fluid (CSF) is obtained, spinal medication (1.6 - 1.8 ml of bupivacaine 0.75% with hyperbaric dextrose, 10 µgm fentanyl, 200 µgm morphine). Most patients receive oxytocin infusion titrated to uterine tone (3-5 units/hr) and ondansetron for prevention of postoperative nausea and vomiting after delivery of the baby.

Conditions

Hypotension During Cesarean Delivery; Spinal Anesthesia

Keywords

cardiac output pregnancy spinal anesthesia

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Control group

The care provider will use blood pressure and heart rate data to administer vasopressor use. In the control group, vasopressors (phenylephrine and ephedrine) will be used as considered appropriate to maintain BP within 20% of baseline. The CO data is measured and blinded to the anesthesiologists in the control group, therefore the anesthesiologist choice of ephedrine or phenylephrine is based on the individual anesthesiologist standard of care preference

Group Type: NO_INTERVENTION

No interventions assigned to this group

Study group

The care provider will use the cardiac output monitor data (intervention) to guide vasopressors (Phenylephrine and ephedrine) in addition to blood pressure and heart rate data based on a standardized protocol in addition to the blood pressure and heart rate data available in the control group.

Group Type: EXPERIMENTAL

Cardiac output monitor data

Intervention Type: DEVICE

The availability of cardiac output monitor provides additional hemodynamic indices that may help guide anesthesiologists to better select vasopressors

Interventions

Cardiac output monitor data

The availability of cardiac output monitor provides additional hemodynamic indices that may help guide anesthesiologists to better select vasopressors

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Healthy pregnant subjects

Exclusion Criteria

• Other than healthy
• High blood pressure. Presumed excessive bleeding, medications for blood pressure

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 40 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Brigham and Women's Hospital

OTHER

Sponsor Role: lead

Responsible Party

Bhavani Shankar Kodali

Vice Chair, Anesthesiology

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Bhavani Shankar Kodali, MD

Role: PRINCIPAL_INVESTIGATOR

Brigham and Women's Hospital

Locations

Brigham and Women's Hospital

Boston, Massachusetts, United States

Countries

United States

Other Identifiers

2013-p-001314

Identifier Type: -

Identifier Source: org_study_id